optical mapping
Bionano Genomics Posts 24 Percent Drop in Q4 Revenues
This year, the company hopes to install 15 to 20 new optical genome mapping systems at existing customer sites that are expanding capacity as well as at new sites.
Bionano Genomics Restructures Debt, Initiates $10M Direct Offering
The optical genome mapping firm deferred its December 2024 amortization payment and reduced payments in the first half of 2025 to improve its cash position, and separately announced a $10 million direct stock offering.
Bionano Genomics' Chinese Partner Nabs NMPA Approval for Saphyr OGM Platform
With the approval, Bionano's OEM partner Hangzhou Diagens Biotechnology can now sell the platform directly to hospitals and clinical labs in China.
Bionano Genomics Shifts Focus to Existing Users, Plans Further Layoffs as Q3 Revenues Fall Short
Premium
Strapped for cash, the optical genome mapping company's Q3 revenues declined 34 percent year over year, falling below the Wall Street consensus estimate.
Bionano Genomics to Raise $3M in Direct Stock Offering
The company also adjourned a special stockholder meeting to Nov. 27 to vote on the issuance of unregistered clinical milestone-linked warrants it placed in July.